Lifeward Ltd. (LFWD)
NASDAQ: LFWD · Real-Time Price · USD
6.01
-0.47 (-7.25%)
Mar 24, 2026, 10:13 AM EDT - Market open
Lifeward Revenue
In the year 2025, Lifeward had annual revenue of $22.03M, down -14.14%.
Revenue (ttm)
$22.03M
Revenue Growth
-14.14%
P/S Ratio
0.42
Revenue / Employee
$275,425
Employees
80
Market Cap
9.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.03M | -3.63M | -14.14% |
| Dec 31, 2024 | 25.66M | 11.81M | 85.24% |
| Dec 31, 2023 | 13.85M | 8.34M | 151.39% |
| Dec 31, 2022 | 5.51M | -455.00K | -7.63% |
| Dec 31, 2021 | 5.97M | 1.57M | 35.81% |
| Dec 31, 2020 | 4.39M | -480.00K | -9.85% |
| Dec 31, 2019 | 4.87M | -1.67M | -25.55% |
| Dec 31, 2018 | 6.55M | -1.21M | -15.58% |
| Dec 31, 2017 | 7.75M | 1.88M | 32.10% |
| Dec 31, 2016 | 5.87M | 2.12M | 56.67% |
| Dec 31, 2015 | 3.75M | -205.00K | -5.19% |
| Dec 31, 2014 | 3.95M | 2.36M | 148.80% |
| Dec 31, 2013 | 1.59M | 616.00K | 63.37% |
| Dec 31, 2012 | 972.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AVITA Medical | 71.61M |
| Trinity Biotech | 48.57M |
| Vivos Therapeutics | 17.32M |
| Beyond Air | 6.92M |
| Biomerica | 4.46M |
| Tenon Medical | 3.94M |
| Sintx Technologies | 1.02M |
| Nexalin Technology | 156.93K |
LFWD News
- 6 days ago - Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 11 days ago - Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company - GlobeNewsWire
- 13 days ago - Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 13 days ago - Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 - GlobeNewsWire
- 22 days ago - Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton - GlobeNewsWire
- 27 days ago - Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors - GlobeNewsWire
- 4 weeks ago - Lifeward Announces Reverse Share Split - GlobeNewsWire
- 5 weeks ago - Lifeward's ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers - GlobeNewsWire